Cipla to invest around Rs. 600 crore in R&D this year: Y K Hamied.

Pharma major Cipla Ltd. recently said it would spend around Rs. 600 crore in research and development during this year to implement research oriented projects.

'Innovation is an integral part of Cipla's success in R&D. This year we will spend around Rs. 600 crore in R&D and efforts are directed towards accountable and implementable research- oriented projects.


'We have been granted many patents in the field of pharmaceuticals,' Cipla Chairman Y K Hamied told shareholders at the company's 78th Annual General Meeting (AGM) here.

Cipla's R&D expenses increased from 5.1 per cent of its total revenue in FY 2012-13 to 5.4 per cent in FY2013-14.


ET